<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38058998</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2750-6665</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>NeuroImmune pharmacology and therapeutics</Title><ISOAbbreviation>NeuroImmune Pharm Ther</ISOAbbreviation></Journal><ArticleTitle>Blood-brain barrier breakdown in COVID-19 ICU survivors: an MRI pilot study.</ArticleTitle><Pagination><StartPage>333</StartPage><EndPage>338</EndPage><MedlinePgn>333-338</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1515/nipt-2023-0018</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">Coronavirus disease 2019 (COVID-19) results in severe inflammation at the acute stage. Chronic neuroinflammation and abnormal immunological response have been suggested to be the contributors to neuro-long-COVID, but direct evidence has been scarce. This study aims to determine the integrity of the blood-brain barrier (BBB) in COVID-19 intensive care unit (ICU) survivors using a novel MRI technique.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">COVID-19 ICU survivors (n=7) and age and sex-matched control participants (n=17) were recruited from June 2021 to March 2023. None of the control participants were hospitalized due to COVID-19 infection. The COVID-19 ICU survivors were studied at 98.6 &#xb1; 14.9 days after their discharge from ICU. A non-invasive MRI technique was used to assess the BBB permeability to water molecules, in terms of permeability surface area-product (PS) in the units of mL/100&#x202f;g/min.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">PS was significantly higher in COVID-19 ICU survivors (p=0.038) when compared to the controls, with values of 153.1 &#xb1; 20.9 mL/100&#x202f;g/min and 132.5 &#xb1; 20.7 mL/100&#x202f;g/min, respectively. In contrast, there were no significant differences in whole-brain cerebral blood flow (p=0.649) or brain volume (p=0.471) between the groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">There is preliminary evidence of a chronic BBB breakdown in COVID-19 survivors who had a severe acute infection, suggesting a plausible contributor to neurological long-COVID symptoms.</AbstractText><CopyrightInformation>&#xa9; 2023 the author(s), published by De Gruyter, Berlin/Boston.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Russell H. Morgan Department of Radiology &amp; Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Dengrong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Russell H. Morgan Department of Radiology &amp; Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rando</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanduja</LastName><ForeName>Shivalika</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Zixuan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The Russell H. Morgan Department of Radiology &amp; Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hazel</LastName><ForeName>Kaisha</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The Russell H. Morgan Department of Radiology &amp; Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pottanat</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The Russell H. Morgan Department of Radiology &amp; Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Ebony</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>The Russell H. Morgan Department of Radiology &amp; Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Cuimei</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The Russell H. Morgan Department of Radiology &amp; Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Doris</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Russell H. Morgan Department of Radiology &amp; Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasar</LastName><ForeName>Sevil</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Sung-Min</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neurosurgery, Surgery, Anesthesiology, and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Hanzhang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Russell H. Morgan Department of Radiology &amp; Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Research Institute, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P41 EB031771</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS106702</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS106711</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG071515</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 HD103538</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 HL157610</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG064792</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 NS100588</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UF1 NS100588</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>NeuroImmune Pharm Ther</MedlineTA><NlmUniqueID>9918418388006676</NlmUniqueID><ISSNLinking>2750-6665</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">WEPCAST</Keyword><Keyword MajorTopicYN="N">blood-brain barrier</Keyword><Keyword MajorTopicYN="N">permeability</Keyword></KeywordList><CoiStatement>Competing interests: Authors have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>7</Day><Hour>4</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38058998</ArticleId><ArticleId IdType="pmc">PMC10696574</ArticleId><ArticleId IdType="doi">10.1515/nipt-2023-0018</ArticleId><ArticleId IdType="pii">nipt-2023-0018</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533&#x2013;4. doi: 10.1016/s1473-3099(20)30120-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;15. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382:2268&#x2013;70. doi: 10.1056/nejmc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J, Msika E-F, Queneau M, Farid K, Paquet C. Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J Neurol. 2022;269:44&#x2013;6. doi: 10.1007/s00415-021-10655-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10655-x</ArticleId><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A, Shah M, Ahmad SA, Premraj L, Wildi K, Li Bassi G, et al. Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells. 2023;12:816. doi: 10.3390/cells12050816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050816</ArticleId><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565&#x2013;71. doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H, Ernst T, Oishi K, Ryan MC, Herskovits E, Cunningham E, et al. Abnormal brain diffusivity in participants with persistent neuropsychiatric symptoms after COVID-19. Neuroimmune Pharmacol Ther. 2023;2:37&#x2013;48. doi: 10.1515/nipt-2022-0016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/nipt-2022-0016</ArticleId><ArticleId IdType="pmc">PMC10091517</ArticleId><ArticleId IdType="pubmed">37067870</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang D, Comish P, Kang R. The hallmarks of COVID-19 disease. PLoS Pathog. 2020;16:e1008536. doi: 10.1371/journal.ppat.1008536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008536</ArticleId><ArticleId IdType="pmc">PMC7244094</ArticleId><ArticleId IdType="pubmed">32442210</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonetto V, Pasetto L, Lisi I, Carbonara M, Zangari R, Ferrari E, et al. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations. Front Immunol. 2022;13:1&#x2013;14. doi: 10.3389/fimmu.2022.1070379.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1070379</ArticleId><ArticleId IdType="pmc">PMC9798841</ArticleId><ArticleId IdType="pubmed">36591311</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao X, Ma SJ, Casey M, D&#x2019;Orazio L, Ringman JM, Wang DJJ. Mapping water exchange across the blood&#x2013;brain barrier using 3D diffusion-prepared arterial spin labeled perfusion MRI. Magn Reson Med. 2019;81:3065&#x2013;79. doi: 10.1002/mrm.27632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.27632</ArticleId><ArticleId IdType="pmc">PMC6414249</ArticleId><ArticleId IdType="pubmed">30561821</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillmer L, Erhardt EB, Caprihan A, Adair JC, Knoefel JE, Prestopnik J, et al. Blood-brain barrier disruption measured by albumin index correlates with inflammatory fluid biomarkers. J Cereb Blood Flow Metab. 2023;43:712&#x2013;21. doi: 10.1177/0271678x221146127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678x221146127</ArticleId><ArticleId IdType="pmc">PMC10108191</ArticleId><ArticleId IdType="pubmed">36522849</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Z, Li Y, Su P, Mao D, Wei Z, Pillai JJ, et al. Non-contrast MR imaging of blood-brain barrier permeability to water. Magn Reson Med. 2018;80:1507&#x2013;20. doi: 10.1002/mrm.27141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.27141</ArticleId><ArticleId IdType="pmc">PMC6097906</ArticleId><ArticleId IdType="pubmed">29498097</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Z, Jiang D, Liu D, Li Y, Uh J, Hou X, et al. Noncontrast assessment of blood&#x2013;brain barrier permeability to water: shorter acquisition, test&#x2013;retest reproducibility, and comparison with contrast-based method. Magn Reson Med. 2021;86:143&#x2013;56. doi: 10.1002/mrm.28687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.28687</ArticleId><ArticleId IdType="pmc">PMC8466682</ArticleId><ArticleId IdType="pubmed">33559214</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson MA, Rhea EM, Knopp RC, Banks WA. Interactions of sars-cov-2 with the blood&#x2013;brain barrier. Int J Mol Sci. 2021;22:1&#x2013;28. doi: 10.3390/ijms22052681.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052681</ArticleId><ArticleId IdType="pmc">PMC7961671</ArticleId><ArticleId IdType="pubmed">33800954</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexopoulos H, Magira E, Bitzogli K, Kafasi N, Vlachoyiannopoulos P, Tzioufas A, et al. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: studies in 8 stuporous and comatose patients. Neurol Neuroimmunol Neuroinflamm. 2020;7:4&#x2013;8. doi: 10.1212/nxi.0000000000000893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/nxi.0000000000000893</ArticleId><ArticleId IdType="pmc">PMC7577546</ArticleId><ArticleId IdType="pubmed">32978291</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-S&#xe1;nchez CM, D&#xed;az-Maroto I, Fern&#xe1;ndez-D&#xed;az E, S&#xe1;nchez-Larsen &#xc1;, Layos-Romero A, Garc&#xed;a-Garc&#xed;a J, et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95:E1060&#x2013;70. doi: 10.1212/wnl.0000000000009937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000009937</ArticleId><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Zachariou V, Pappas C, Bauer CE, Shao X, Liu P, Lu H, et al. Regional differences in the link between water exchange rate across the blood&#x2013;brain barrier and cognitive performance in normal aging. GeroScience. 2023:1&#x2013;18. doi: 10.1007/s11357-023-00930-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-023-00930-2</ArticleId><ArticleId IdType="pmc">PMC10828276</ArticleId><ArticleId IdType="pubmed">37713089</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Z, Sur S, Liu P, Li Y, Jiang D, Hou X, et al. Blood&#x2013;brain barrier breakdown in relationship to Alzheimer and vascular disease. Ann Neurol. 2021;90:227&#x2013;38. doi: 10.1002/ana.26134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26134</ArticleId><ArticleId IdType="pmc">PMC8805295</ArticleId><ArticleId IdType="pubmed">34041783</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, et al. APOE4 leads to blood&#x2013;brain barrier dysfunction predicting cognitive decline. Nature. 2020;581:71&#x2013;6. doi: 10.1038/s41586-020-2247-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2247-3</ArticleId><ArticleId IdType="pmc">PMC7250000</ArticleId><ArticleId IdType="pubmed">32376954</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Z, Lance E, McIntyre T, Li Y, Liu P, Lim C, et al. Imaging blood&#x2013;brain barrier permeability through MRI in pediatric sickle cell disease: a feasibility study. J Magn Reson Imaging. 2022;55:1551&#x2013;8. doi: 10.1002/jmri.27965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.27965</ArticleId><ArticleId IdType="pmc">PMC9018466</ArticleId><ArticleId IdType="pubmed">34676938</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosey MM, Needham DM. Survivorship after COVID-19 ICUstay. Nat Rev Dis Prim. 2020;6:60. doi: 10.1038/s41572-020-0201-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-020-0201-1</ArticleId><ArticleId IdType="pmc">PMC7362322</ArticleId><ArticleId IdType="pubmed">32669623</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain B, Fang C, Chang J. Blood&#x2013;brain barrier breakdown: an emerging biomarker of cognitive impairment in normal aging and dementia. Front Neurosci. 2021;15:688090. doi: 10.3389/fnins.2021.688090.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.688090</ArticleId><ArticleId IdType="pmc">PMC8418300</ArticleId><ArticleId IdType="pubmed">34489623</ArticleId></ArticleIdList></Reference><Reference><Citation>Klinkhammer S, Horn J, Duits AA, Visser-Meily JMA, Verwijk E, Slooter AJC, et al. Neurological and (neuro)psychological sequelae in intensive care and general ward COVID-19 survivors. Eur J Neurol. 2023;30:1880&#x2013;90. doi: 10.1111/ene.15812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15812</ArticleId><ArticleId IdType="pubmed">37010152</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Zhang C, Qiu Y, Chen A, Li Y, Hu B. Dysfunction of the blood-brain barrier in cerebral microbleeds: from bedside to bench. Aging Dis. 2021;12:1898. doi: 10.14336/ad.2021.0514.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/ad.2021.0514</ArticleId><ArticleId IdType="pmc">PMC8612614</ArticleId><ArticleId IdType="pubmed">34881076</ArticleId></ArticleIdList></Reference><Reference><Citation>Perico N, Cortinovis M, Suter F, Remuzzi G. Home as the new Frontier for the treatment of COVID-19: the case for anti-inflammatory agents. Lancet Infect Dis. 2023;23:e22&#x2013;33. doi: 10.1016/s1473-3099(22)00433-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(22)00433-9</ArticleId><ArticleId IdType="pmc">PMC9411261</ArticleId><ArticleId IdType="pubmed">36030796</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimarco V, Izzo R, Lombardi A, Coppola A, Fiorentino G, Santulli G. Beneficial effects of L-Arginine in patients hospitalized for COVID-19: new insights from a randomized clinical trial. Pharmacol Res. 2023;191:106702. doi: 10.1016/j.phrs.2023.106702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2023.106702</ArticleId><ArticleId IdType="pmc">PMC9928676</ArticleId><ArticleId IdType="pubmed">36804278</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahedian-Azimi A, Abbasifard M, Rahimi-Bashar F, Guest PC, Majeed M, Mohammadi A, et al. Effectiveness of curcumin on outcomes of hospitalized COVID-19 patients: a systematic review of clinical trials. Nutrients. 2022;14:256. doi: 10.3390/nu14020256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14020256</ArticleId><ArticleId IdType="pmc">PMC8779570</ArticleId><ArticleId IdType="pubmed">35057437</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisoschi AM, Pop A, Iordache F, Stanca L, Geicu OI, Bilteanu L, et al. Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy. Eur J Med Chem. 2022;232:114175. doi: 10.1016/j.ejmech.2022.114175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2022.114175</ArticleId><ArticleId IdType="pmc">PMC8813210</ArticleId><ArticleId IdType="pubmed">35151223</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen JF, Thomsen T, Overgaard D, Bestle MH, Christensen D, Egerod I. Impact of follow-up consultations for ICU survivors on post-ICU syndrome: a systematic review and meta-analysis. Intensive Care Med. 2015;41:763&#x2013;75. doi: 10.1007/s00134-015-3689-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3689-1</ArticleId><ArticleId IdType="pubmed">25731633</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>